Verastem Oncology News, Verastem Oncology Quote, VSTM Quote

Verastem Oncology (NQ:VSTM) Delayed: 9.61 -0.13 (1.33%)

Prev. Close

$9.74

Open

$9.68

52 Wk High

$2.43

52 Wk Low

$1.05

Day High

$9.93

Day Low

$9.58

P/E

N/A

EPS

$-1.79

Volume

101,625

Apr 18, 2024 04:05 PM Verastem Oncology (VSTM) Appoints John Hayslip to Chief Medical Officer
Apr 18, 2024 04:05 PM Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
Apr 12, 2024 04:05 PM Form DEF 14A Verastem, Inc. For: May 23
Apr 9, 2024 05:11 PM Form 8-K Verastem, Inc. For: Apr 09
Apr 9, 2024 07:00 AM GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
Apr 8, 2024 04:30 PM Form 4 Verastem, Inc. For: Apr 05 Filed by: Calkins Daniel
Apr 4, 2024 07:30 AM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 27, 2024 04:31 PM Form 4 Verastem, Inc. For: Mar 25 Filed by: Calkins Daniel
Mar 21, 2024 04:33 PM Form 4 Verastem, Inc. For: Mar 20 Filed by: Calkins Daniel
Mar 20, 2024 05:37 PM Form 4 Verastem, Inc. For: Mar 18 Filed by: Gagnon Robert E.

Entities mentioned with vstm